tert-Butyl 2-bromo-7-oxo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate

Catalog No. :
ACCTFZ629
CAS No. :
1822861-49-3
Molecular Formula :
C11H13BrN2O3S
Molecular Weight :
333.21

IUPAC Name:tert-butyl 2-bromo-7-oxo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate

tert-Butyl 2-bromo-7-oxo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$270.00Login to see priceInquiryInquiry
100mg95%$393.00Login to see priceInquiryInquiry
250mg95%$867.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-bromo-7-oxo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate
IUPAC Nametert-butyl 2-bromo-7-oxo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate
MDL No.MFCD28133587
Molecular FormulaC11H13BrN2O3S
Molecular Weight333.21
SMILESO=C(N(CC1=C2SC(Br)=N1)CC2=O)OC(C)(C)C
InChI KeyNXBCSBQYJDBTJT-UHFFFAOYSA-N
Synonymtert-butyl 2-bromo-7-oxo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4h)-carboxylate;Thiazolo[4,5-c]pyridine-5(4H)-carboxylic acid, 2-bromo-6,7-dihydro-7-oxo-, 1,1-dimethylethyl ester
CAS No.1822861-49-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCTFZ629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCTFZ629 route product structure diagram
    ACCTFZ6291822861-49-3
Inquiry

2. ACCTFZ629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCTFZ629 route product structure diagram
    ACCTFZ6291822861-49-3
Inquiry

Comments (0)